Immundiagnostik AG of Bensheim at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine
Manufacturers

Immundiagnostik AG

Stubenwald-Allee 8 A, 64625 Bensheim
Germany
Telephone +49 6251 701900
Fax +49 6251 849430
info@immundiagnostik.com

Hall map

MEDICA 2018 hall map (Hall 3): stand E59

Fairground map

MEDICA 2018 fairground map: Hall 3

Contact

Dr. Karl Wintgens

Phone
00491727189895

Email
k.f.wintgens@immundiagnostik.com

Our range of products

Product categories

  • 02  Laboratory Techology
  • 02.03  Chromatographs

Chromatographs

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.02  Haemoglobin testing, electrophoresis testing

Haemoglobin testing, electrophoresis testing

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.03  Urinalysis equipment and systems

Urinalysis equipment and systems

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.04  Rapid tests in clinical chemistry

Rapid tests in clinical chemistry

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.05  Other equipment for clinical chemistry

Other equipment for clinical chemistry

  • 03  Diagnostics
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.01  Immuno assay testing

Immuno assay testing

  • 03  Diagnostics
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.03  Diagnostic tests for cancer

Diagnostic tests for cancer

  • 03  Diagnostics
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.04  Other molecular diagnostics testing

Other molecular diagnostics testing

  • 03  Diagnostics
  • 03.07  Other diagnostics

Other diagnostics

Our products

Product category: Immuno assay testing

IDK® Zonulin ELISA

Zonulin is a novel human protein analogue to the zonula occludens toxin derived
from Vibrio cholerae which participates in tight junctions between cells of the wall
of the digestive tract. Zonulin binds to a specific receptor on the surface of intestinal
epithelia and triggers a cascade of biochemical events which induces tight junction
disassembly and a subsequent permeability increase of the intestinal epithelia, allowing
some substances to pass through and activate immune reactions.
Fasano and his co-workers found that the zonulin-zonulin-receptor-system is more
activated in celiac disease and type 1 diabetes mellitus patients. Patients with active
celiac disease showed higher levels of zonulin and anti-zonulin antibodies compared
to non-celiac patients and patients in remission, who were on a gluten-free diet.
Concerning the autoimmune type 1 diabetes, in experiments with rats it could be
demonstrated that elevated zonulin levels as well as increased intestinal permeability
precede a type 1 diabetes disease. Conversely, type 1 diabetes could be prevented
by inhibition of zonulin in animal experiments.
In addition, it was reported that many people who suffer from celiac disease also suffer
from other autoimmune disorders. It is suggested that increased levels of zonulin
are a contributing factor to the development of celiac disease and other autoimmune
disorders such as insulin dependent diabetes, multiple sclerosis and rheumatoid
arthritis.

More Less

About us

Company details

Immundiagnostik AG (www.immundiagnostik.com), founded in 1986 by Dr. Franz Paul Armbruster (CEO), is specialized on the development, production, and world-wide distribution of innovative parameters and detection methods for laboratory diagnostics and medical research. The main focus is the development of immunological tools, of HPLC and molecular biology methods, and of new applications for mass spectrometry (LC-MS/MS). Immundiagnostik concentrates on the development and production of laboratory diagnostics for the identification of disease risks, for differential diagnosis, and for therapeutic drug monitoring. The company holds a particularly strong portfolio in markers of oxidative stress/anti-aging, gastroenterology and nutrition, skeletal system, and cardio-reno-vascular system. Immundiagnostik owns more than 35 patents in Europe, the US, Japan, Canada, and Australia, is certified according to DIN EN ISO 13485 and fulfills the requirements of the German Medical Device Regulation and the EU IVD Regulations (98/79 EG).

More Less

Company data

Sales volume

10-49 Mio US $

Export content

max. 75%

Number of employees

100-499

Foundation

1986

Area of business

Diagnostics